Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,365
  • Shares Outstanding, K 2,804
  • Annual Sales, $ 4,940 K
  • Annual Income, $ -8,160 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 0.31
  • Price/Sales 0.81
  • Price/Cash Flow N/A
  • Price/Book 0.35

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +16.37%
on 11/21/25
1.6800 -21.73%
on 11/17/25
-0.3900 (-22.87%)
since 11/14/25
3-Month
1.1300 +16.37%
on 11/21/25
2.4999 -47.40%
on 10/08/25
-1.0050 (-43.32%)
since 09/16/25
52-Week
1.1300 +16.37%
on 11/21/25
8.2700 -84.10%
on 01/21/25
-3.8750 (-74.66%)
since 12/16/24

Most Recent Stories

More News
InMed Provides Update on BayMedica Commercial Business

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.3150 (+9.58%)
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Data demonstrate a favorable bioavailability profile of INM-901 oral formulationData will support design and planning of first in human clinical trialsPreparing for pre-IND meeting with the FDA Vancouver,...

INM : 1.3150 (+9.58%)
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update

Vancouver, British Columbia--(Newsfile Corp. - November 6, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical drug development company focused on developing a...

INM : 1.3150 (+9.58%)
InMed Pharmaceuticals Strengthens Board with Strategic Appointment

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. InMed Pharmaceuticals...

INM : 1.3150 (+9.58%)
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - October 16, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.3150 (+9.58%)
InMed Pharmaceuticals Strengthens Board with Appointment of Industry Veteran Neil Klompas

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update...

INM : 1.3150 (+9.58%)
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.3150 (+9.58%)
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update

Advances INM-901 program, addressing multiple key biological pathways implicated in Alzheimer's disease pathologyFurther develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related...

INM : 1.3150 (+9.58%)
InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary...

INM : 1.3150 (+9.58%)
InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025

Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activityVancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc. (NASDAQ:...

INM : 1.3150 (+9.58%)

Business Summary

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

See More

Key Turning Points

3rd Resistance Point 1.3967
2nd Resistance Point 1.3583
1st Resistance Point 1.3367
Last Price 1.3150
1st Support Level 1.2767
2nd Support Level 1.2383
3rd Support Level 1.2167

See More

52-Week High 8.2700
Fibonacci 61.8% 5.5425
Fibonacci 50% 4.7000
Fibonacci 38.2% 3.8575
Last Price 1.3150
52-Week Low 1.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar